PMOS / PCOS · Long Term Health

Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated

Legro RS, Urbanek M, Kunselman AR, Leiby BE, Dunaif A

Published July 4, 2002 Fertility and Sterility, 78(1), 51-57
DOI 10.1016/s0015-0282(02)03153-9 PMID 12095490

Abstract

Objective

To determine whether self-selected women with polycystic ovary syndrome (PCOS) are abnormal compared with a control population.

Design

Case-control.

Setting

Support group meeting organized and initiated by patients.

Patients

Forty-five self-selected women with PCOS and 80 control women.

Interventions

Self-selected women with PCOS at a peer support conference completed a questionnaire, had a brief physical, and gave a fasting blood sample.

Main Outcome Measures

Historical, biometric, and assay results.

Results

Sixty percent of the women attending the conference participated in the study. Most had been diagnosed with PCOS on the basis of ovarian morphology (35%). They were more likely to be nulliparous and have a history of oligomenorrhea (96%). They were hyperandrogenemic (significantly elevated testosterone and DHEAS levels) compared with control women. Self-selected women with PCOS displayed multiple metabolic abnormalities compared with control women, including elevations in blood pressure, waist-hip ratio, fasting insulin, fasting total cholesterol, and fasting low-density lipoprotein cholesterol levels, as well as a significant decrease in fasting glucose-insulin ratio and high-density lipoprotein cholesterol levels.

Conclusions

Self-selected women with PCOS have reproductive and metabolic abnormalities. The majority of these women received inadequate treatment despite having risk factors for endometrial cancer, diabetes, and/or heart disease. Our study also suggests that women attending or participating in a PCOS support group are willing and likely to participate in clinical studies.

Topics

By this author

Related research

PMOS / PCOS › Long Term Health › Metabolic Risk · Reproductive Endocrinology › Ovarian Hormones › Androgens · Menstrual Cycle › Cycle Disorders › Ovulatory Disturbances
Richard S Legro, Margrit Urbanek, Allen R Kunselman, Benjamin E Leiby, Andrea Dunaif
Rick Legro, Dick Legro, Rich Legro, R Legro, M Urbanek, A Kunselman, Ben Leiby, B Leiby, A Dunaif
PMID 12095490 12095490 DOI 10.1016/s0015-0282(02)03153-9 10.1016/s0015-0282(02)03153-9 Legro et al. 2002, Legro 2002